Vital Images names new CEOVisualization software developer Vital Images has appointed Albert Emola as president and CEO. Emola takes over from chairman Douglas Pihl, who has been interim president and CEO of the Minneapolis-based firm since
Visualization software developer Vital Images has appointed Albert Emola as president and CEO. Emola takes over from chairman Douglas Pihl, who has been interim president and CEO of the Minneapolis-based firm since Andrew Weiss resigned in early 1998. Emola, who was also elected to the companys board of directors, has held key positions at a number of healthcare and medical device companies over the past 15 years. Since January 1999 he served as a management consultant to several medical-device start-ups, where he was responsible for creating business and operating plans, financing, licensing, and technology transfer strategies.
© 2000 Miller Freeman, Inc., a United News & Media company
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.